Venous thromboembolism treatment involves segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis devices and upper pneumatic compression sleeves.
DUBAI, United Arab Emirates, Venous thromboembolism treatment involves segmented pneumatic compression pumps without gradient, segmented pneumatic compression pumps with calibrated gradient, lower pneumatic compression sleeves, non-segmented pneumatic compression pumps permanent inferior vena cava filters, retrievable inferior vena cava filters, embolectomy balloon catheters, percutaneous thrombectomy devices, catheter-directed thrombolysis (CDT) devices and upper pneumatic compression sleeves. Based on the disease indication, deep vein thrombosis is expected to hold a prominent share in the overall venous thromboembolism treatment market.
Request a report sample to gain comprehensive insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-1341
The global demand for venous thromboembolism treatment market is likely to grow steadily over the forthcoming years. As indicated by a recent Future Market Insights (FMI) study, the market revenues will observe approximately 3.7% CAGR between 2022 and 2029. More than 3/5th of treatment demand is underpinned by deep venous thrombosis, according to the report. Catheter-directed thrombolysis devices and percutaneous thrombectomy devices, collectively account for more than half of the global revenues represented by the venous thromboembolism treatment market.
Poor Reimbursement Scenario Against High Treatment Costs to Restrict Adoption
Several factors influence the overall growth of the Venous Thromboembolism Treatment market. The first and most important factor driving the market for venous thromboembolism treatment is the increasing prevalence of venous thromboembolism. Other factors such as increasing rates of varicose filter extraction, increasing health awareness, availability of favorable reimbursement policies, and increasing geriatric population are also responsible for the growth of the venous thromboembolism treatment market.
Apart from the driving factors in the Venous Thromboembolism Treatment market, there are several factors that might hinder the overall growth of the Venous Thromboembolism Treatment market. The high cost of venous thromboembolism treatment, poor reimbursement of some treatment facilities and poor insurance support are some of the main factors expected to hinder the growth of the venous thromboembolism treatment market.
For any Queries Related with the Report, Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-1341
Drug-based Treatment Witnessing Traction across Europe
Although the increasing preference for venous thromboembolic treatment is likely to constrain market growth, new generation drugs are being evaluated, including oral anticoagulants (NOACs) that are not vitamin K antagonists such as dabigatran, rivaroxaban, apixaban and edoxaban. to increase the rate of treatment for venous thromboembolism due to increased efficacy. However, this trend shows regional differences.
North America is expected to be a leading region in the global venous thromboembolic treatment market due to the well-developed healthcare infrastructure and various technological advances in the region. The increasing prevalence of venous thromboembolism is also responsible for stimulating market growth in North America. In North America, increased acceptance of treatment with mechanical prevention systems and interventions is expected in the forecast period. In addition, drug treatment is expected to gain popularity in the European region, which is likely to reduce the use of mechanical treatments and interventions in the region.
On the other hand, an increase in health care spending per capita is one of the macroeconomic factors that should stimulate the market. Currently, some changes in the socio-economic scenario could also lead to a significant growth in the Venous Thromboembolism Treatment market.
We Offer tailor-made Solutions to fit Your Requirements, Request Customization @
https://www.futuremarketinsights.com/customization-available/rep-gb-1341
Tier 1 Players Account for Nearly 35% Market Revenue Share
Some of the key manufacturers of venous thromboembolism treatment are mainly focusing on innovating and launching new and advanced products. Major players in the venous thromboembolism treatment market are focusing on collaborations and acquisitions. For example, venous thromboembolism treatment is majorly adopted by hospitals, catheterisation laboratories, and ambulatory surgical centres. Hospitals are expected to hold a significant revenue share in the venous thromboembolism treatment market.
The report tracks some of the key companies operating in the venous thromboembolism treatment market such as ArjoHuntleigh AB, AngioDynamics, Cardinal Health Inc., BTG International Ltd., Stryker Corporation, DJO Global Inc., EKOS Corp, and Teleflex Inc., Boston Scientific Corp. There are several other companies operating in the venous thromboembolism treatment market. AngioDynamics, Boston Scientific Corp., and Cardinal Health Inc. are expected to hold a prominent share in the venous thromboembolism treatment market. These tier 1 companies hold a share of approximately 35% in the venous thromboembolism treatment market.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Venous Reservoirs Market - This Venous Reservoirs market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study.
Chronic Venous Occlusions Treatment Market - Chronic venous occlusions treatment is used to treat chronic venous occlusions. The treatment of clots in the deep vein with an anticoagulant may be resolved or may cause scar inside the tissue. The scar caused inside the tissue of the vein either damage the valves by causing backward flow or can cause blockage in the vein due to abnormal blood flow to the heart.
Venous device Market - According to the latest research by Future Market Insights, Venous device market is set to experience 6.5% growth during the year 2021-2031. Venous devices are designed catheters to maintain the access to the venous system. There are two types of venous devices in the market that are peripheral venous device and central venous catheters.
About Future Market Insights (FMI)
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/venous-thromboembolism-treatment-market